ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Return
7.83%
This Quarter Return
+22.97%
1 Year Return
-7.83%
3 Year Return
+43.87%
5 Year Return
+57.06%
10 Year Return
–
AUM
$330M
AUM Growth
+$23.6M
(+7.7%)
Cap. Flow
-$25.9M
Cap. Flow
% of AUM
-7.84%
Top 10 Holdings %
Top 10 Hldgs %
23.73%
Holding
867
New
137
Increased
211
Reduced
242
Closed
50
Top Buys
| 1 |
Stellantis
STLA
|
+$12.3M |
| 2 |
Vale
VALE
|
+$3.01M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.45M |
| 4 |
Coca-Cola
KO
|
+$2.33M |
| 5 |
Wells Fargo
WFC
|
+$1.84M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
+$15M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$9.54M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$7.58M |
| 4 |
Logitech
LOGI
|
+$6.71M |
| 5 |
UBS Group
UBS
|
+$5.89M |
Sector Composition
| 1 | Consumer Discretionary | 15.9% |
| 2 | Technology | 13.76% |
| 3 | Healthcare | 13.5% |
| 4 | Financials | 11.26% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
376
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $111K | 0.03% |
6,150
+320
| +5% | +$5.76K |
|
377
Snap-on
SNA
$16.8B
| $109K | 0.03% |
635
+455
| +253% | +$77.9K |
|
378
Sarepta Therapeutics
SRPT
$1.85B
| $108K | 0.03% |
636
| – | – |
|
|
ZGNX
379
DELISTED
Zogenix, Inc.
ZGNX
| $107K | 0.03% |
5,374
+1,210
| +29% | +$24.2K |
|
380
Steel Dynamics
STLD
$19.2B
| $107K | 0.03% |
2,895
-32,303
| -92% | -$1.19M |
|
381
Carnival Corp
CCL
$42.8B
| $106K | 0.03% |
+4,895
| New | +$106K |
|
382
Republic Services
RSG
$71.5B
| $104K | 0.03% |
1,081
-288
| -21% | -$27.7K |
|
|
RCS
383
PIMCO Strategic Income Fund
RCS
$342M
| $104K | 0.03% |
15,001
| – | – |
|
384
Vanguard Energy ETF
VDE
$7.21B
| $104K | 0.03% |
2,000
| – | – |
|
385
CVS Health
CVS
$91B
| $103K | 0.03% |
1,511
+12
| +0.8% | +$820 |
|
386
General Motors
GM
$55.2B
| $102K | 0.03% |
2,442
-34,739
| -93% | -$1.45M |
|
387
Ralph Lauren
RL
$18.8B
| $99.8K | 0.03% |
962
-2,211
| -70% | -$229K |
|
388
Nuveen Credit Strategies Income Fund
JQC
$750M
| $98.1K | 0.03% |
15,500
| – | – |
|
|
DQ
389
Daqo New Energy
DQ
$1.86B
| $97.3K | 0.03% |
1,696
+626
| +59% | +$35.9K |
|
390
PTC Therapeutics
PTCT
$4.64B
| $96.5K | 0.03% |
1,582
-2,009
| -56% | -$123K |
|
391
Kodak
KODK
$473M
| $96K | 0.03% |
+11,788
| New | +$96K |
|
392
Caterpillar
CAT
$196B
| $95.9K | 0.03% |
+527
| New | +$95.9K |
|
393
KALA BIO
KALA
$98.3M
| $95.3K | 0.03% |
282
+185
| +191% | +$62.5K |
|
|
GHG
394
GreenTree Hospitality
GHG
$206M
| $93.8K | 0.03% |
+7,000
| New | +$93.8K |
|
395
Cidara Therapeutics
CDTX
$1.6B
| $93.4K | 0.03% |
2,336
+543
| +30% | +$21.7K |
|
396
iShares US Financial Services ETF
IYG
$1.92B
| $93K | 0.03% |
+1,860
| New | +$93K |
|
397
Chemed
CHE
$6.74B
| $92.7K | 0.03% |
174
+10
| +6% | +$5.33K |
|
398
Lennar Class A
LEN
$35.6B
| $91.2K | 0.03% |
1,237
-13,004
| -91% | -$959K |
|
399
Boeing
BA
$174B
| $91K | 0.03% |
425
-186
| -30% | -$39.8K |
|
400
Alector
ALEC
$283M
| $89.3K | 0.03% |
5,900
| – | – |
|